# Biomarkers to Predict the Success of Immunosuppression Withdrawal in Autoimmune Hepatitis

> **NCT03711669** · — · UNKNOWN · sponsor: **Hospital Clinic of Barcelona** · enrollment: 96 (estimated)

## Conditions studied

- Autoimmune Hepatitis

## Interventions

- **BEHAVIORAL:** Immunosuppression withdrawal

## Key facts

- **NCT ID:** NCT03711669
- **Lead sponsor:** Hospital Clinic of Barcelona
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-10
- **Primary completion:** 2021-01
- **Final completion:** 2021-04
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2020-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03711669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03711669, "Biomarkers to Predict the Success of Immunosuppression Withdrawal in Autoimmune Hepatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03711669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*